Antares Therapeutics

aid: antares-therapeutics
name: Antares Therapeutics
description: Antares Therapeutics is a Boston- and South San Francisco-based precision medicine company developing small-molecule
  therapies against validated but previously undruggable targets in cancer and other serious diseases. Spun out of Scorpion
  Therapeutics following Eli Lilly's March 2025 acquisition of Scorpion, Antares launched in June 2025 with a $177 million
  Series A co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners and Cormorant Asset Management.
  The company combines medicinal chemistry (proprietary compound libraries and next-generation mass spectrometry to find new
  chemical pockets), target biology (first-in-class preclinically validated targets and allosteric approaches to clinically
  validated ones), and predictive sciences (physics-based modeling, machine learning and molecular dynamics) to shorten discovery
  cycles. Its most advanced program is expected to enter the clinic in 2026, with multiple additional preclinical programs
  and discovery collaborations with Novartis, AstraZeneca and Pierre Fabre Laboratories. Antares is a private, preclinical-stage
  biotechnology company and publishes no public product API, developer portal or SDK surface.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: open
  trial: false
  try_now: false
  public: true
  gated: none
  gated_source:
  - onboarding
  label: Open access
  confidence: low
  source:
  - authentication
  - security
  generated: '2026-11-06'
  method: derived
image: https://antaresrx.com/wp-content/uploads/2025/06/logo-antaresrx-2x.png
url: https://raw.githubusercontent.com/api-evangelist/antares-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: profiled
x-tier-reason: no-public-api-surface
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Precision Medicine
- Oncology
- Drug Discovery
- Life Sciences
- Machine Learning
tags_raw:
- Company
- Biotechnology
- Pharmaceuticals
- Precision Medicine
- Oncology
- Drug Discovery
- Life Sciences
- Machine Learning
- Machine-Learning
apis:
- aid: antares-therapeutics:antaresrx-com-website-wordpress-rest
  name: Antares Therapeutics Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the Antares Therapeutics website at antaresrx.com: the route index
    of the site''s content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://antaresrx.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://antaresrx.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: MCPServer
  url: mcp/antares-therapeutics-mcp.yml
- type: DomainSecurity
  url: security/antares-therapeutics-domain-security.yml
- type: Website
  url: https://antaresrx.com
- type: Blog
  url: https://antaresrx.com/category/press-release/
- type: BlogRSS
  url: https://antaresrx.com/feed/
- type: News
  url: https://antaresrx.com/category/in-the-media/
- type: Careers
  url: https://job-boards.greenhouse.io/antaresrx
- type: TermsOfService
  url: https://antaresrx.com/terms-of-use/
- type: PrivacyPolicy
  url: https://antaresrx.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/antares-therapeutics/
- type: Twitter
  url: https://x.com/antares_rx
- type: Instagram
  url: https://www.instagram.com/antares_rx
- type: WellKnown
  url: well-known/antares-therapeutics-well-known.yml
- type: Authentication
  url: authentication/antares-therapeutics-authentication.yml
- type: Packages
  url: packages/antares-therapeutics-packages.yml
- type: LLMsTxt
  url: llms/antares-therapeutics-llms.txt
- type: VulnerabilityDisclosure
  url: security/antares-therapeutics-vulnerability-disclosure.yml
x-enrichment:
  date: '2026-07-19'
  status: minimal
  artifacts_added: 7
  pass: local-v1
  note: No product API, developer portal, SDK, sandbox, changelog or status page exists. An MCP endpoint was found on the
    domain but it is the WordPress MCP Adapter plugin and returns 401; it is deliberately NOT wired as type MCPServer. No
    first-party packages exist in any registry, and no vulnerability disclosure programme or trust center was verified, so
    no SDKs, Security or Compliance pointers are emitted.